IP Library Granted Patent US 12,653,942
Granted Patent B2
US 12,653,942 · App. 17/864,153 · Granted Jun 16, 2026

Multi-modal wound treatment apparatus

Inventors: Billy Wall (Arrington, TN); Stephen Galbraith (Franklin, TN); Robert Porter (Franklin, TN)
Assignee: Phase One Health, LLC
A61M1/85A61F13/05A61L2/202A61M1/74A61M1/94A61M1/95A61M1/96A61M1/962A61M35/30A61F2013/0028A61M1/75A61M35/25A61M2202/0208A61M2202/0216A61M2205/05A61M2205/3331A61M2209/10A61M2230/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,653,942
App. No.
17/864,153
Granted
Jun 16, 2026
Kind
B2
Abstract

The wound treatment apparatus combines an internal negative pressure (vacuum) pump and an internal positive pressure (compressor) pump connectable to an external oxygen supply for providing both negative pressure wound therapy and hyperbaric oxygen wound therapy to a wound site. The apparatus also includes a user interface operatively connected to an electronic controller that monitors and actuates the vacuum and compressor pumps. The user interface and controller enables the apparatus to provide multiple modes of operation and the ability to selectively change between negative pressure therapy operational modes and hyperbaric oxygen operational modes.

Claims (20)

1 . A portable wound treatment device comprising:

a housing comprising an exterior wall enclosing a device interior, and a user interface panel arranged in the exterior wall;

an oxygen supply connector panel coupled to the exterior wall and including at least one oxygen supply fitting extending through the exterior wall, the oxygen supply fitting configured to couple oxygen provided by an external oxygen source into the device interior;

a wound treatment connector panel coupled to the exterior wall and including a positive pressure fitting and a negative pressure fitting, the positive pressure fitting configured to couple oxygen under positive pressure from the device interior to an external wound dressing, and the negative pressure fitting configured to apply a negative pressure from the device to the external wound dressing and to extract wound exudate from the external wound dressing into the device;

a wound exudate connector panel coupled to the exterior wall and including a positive exudate fitting and a negative exudate fitting extending through the exterior wall, the positive exudate fitting configured to couple wound exudate from the negative pressure fitting to an exudate container, and the negative exudate fitting configured to provide a negative pressure to the exudate container;

a positive pressure pump disposed in the device interior and coupled to the positive pressure fitting, the positive pressure pump effective to provide oxygen under positive pressure to the positive pressure fitting during a hyperbaric oxygen treatment mode;

a negative pressure pump disposed in the device interior and coupled to the negative pressure fitting and to the negative exudate fitting, the negative pressure pump effective to provide negative pressure to the negative pressure fitting and to the negative exudate fitting during a negative pressure treatment mode;

an oxygen concentrator disposed in the device interior and operatively coupled to the positive pressure pump, the oxygen concentrator effective to supply oxygen enriched air to the positive pressure pump during the hyperbaric oxygen treatment mode;

a controller disposed in the device interior;

an oxygen accumulator valve operatively coupled to the controller;

a vacuum accumulator valve operatively coupled to the controller;

an oxygen accumulator fluidly coupled to the compressor pump via the oxygen accumulator valve; and

a vacuum accumulator fluidly coupled to the vacuum pump via the vacuum accumulator valve,

wherein the controller is configured to selectively actuate the oxygen and vacuum accumulator valves to expedite application of positive and negative pressures at the external wound dressing during a transition mode between the positive and negative pressure operational modes.

2 . The portable wound treatment device of claim 1 further comprising:

a supplemental fluid delivery system disposed within the device interior, the supplemental fluid delivery system operatively coupled to the controller and comprising a manifold configured to receive a supplemental wound treatment fluid and to deliver the supplemental wound treatment fluid to the positive pressure fitting; and

the controller is further configured to cause the supplemental fluid delivery system to deliver the supplemental wound treatment fluid to the positive pressure fitting during the hyperbaric oxygen treatment mode.

3 . The portable wound treatment device of claim 1 further comprising:

a self-sterilization system disposed within the device interior, the self-sterilization system operatively coupled to the controller and configured to receive a sterilizing fluid and to deliver the sterilizing fluid to the positive and negative pressure pumps; and

the controller is further configured to cause the self-sterilization system to circulate the sterilizing fluid through the positive pressure pump and through the negative pressure pump during one or more device self-sterilization modes.

Assignments (3)
COURT APPOINTMENT Recorded May 21, 2026
From: INTEGRATED HEALING TECHNOLOGIES, LLC
To: MCLEMORE, JOHN C.
Reel/Frame 075607/0859 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2026
From: MCLEMORE, JOHN C.
To: PHASE ONE HEALTH, LLC
Reel/Frame 074732/0501 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2026
From: WALL, BILLY RUSSELL; PORTER, ROBERT; GALBRAITH, STEPHEN
To: INTEGRATED HEALING TECHNOLOGIES, LLC
Reel/Frame 074716/0479 →
Continuity (9)
Continuation 16154893 · Oct 9, 2018
Continuation 14378306
Provisional Application 61633515 · Feb 13, 2012
Provisional Application 61633527 · Feb 13, 2012
Provisional Application 61633516 · Feb 13, 2012
Provisional Application 61633517 · Feb 13, 2012
Provisional Application 61633528 · Feb 13, 2012
Provisional Application 61633529 · Feb 13, 2012
Related Publication 20230181813A1 · Jun 15, 2023
References Cited (24)
US 4218610A · Baxter et al. · 1980 [cited by applicant]
US 5069880A · Karlson · 1991 [cited by examiner]
US 7524315B2 · Blott et al. · 2009 [cited by applicant]
US 7648488B2 · Smith et al. · 2010 [cited by applicant]
US 8011039B2 · Stryker et al. · 2011 [cited by applicant]
US 8021348B2 · Risk, Jr. · 2011 [cited by examiner]
US 8100956B2 · Quisenberry · 2012 [cited by examiner]
US 8128672B2 · Quisenberry et al. · 2012 [cited by applicant]
US 8273074B2 · Jaeb et al. · 2012 [cited by applicant]
US 8273855B2 · Xiao · 2012 [cited by applicant]
US 8357130B2 · Smith et al. · 2013 [cited by applicant]
US 8425580B2 · Quisenberry et al. · 2013 [cited by applicant]
US 10117975B2 · Wall · 2018 [cited by examiner]
US 11406749B2 · Wall · 2022 [cited by examiner]
US 20070118096A1 · Smith · 2007 [cited by examiner]
US 20070260226A1 · Jaeb · 2007 [cited by examiner]
US 20090293879A1 · Frånberg et al. · 2009 [cited by applicant]
US 20100030132A1 · Niezgoda · 2010 [cited by examiner]
US 20100150991A1 · Bernstein · 2010 [cited by applicant]
EP 1100574 · 2001 [cited by applicant]
KR 101123897 · 2012 [cited by applicant]
WO 2006119473 · 2006 [cited by applicant]
WO 2007062024 · 2007 [cited by applicant]
WO 2008130689 · 2008 [cited by applicant]